Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Recombinant IGF-I: Past, present and future.

Bright GM.

Growth Horm IGF Res. 2016 Jun;28:62-5. doi: 10.1016/j.ghir.2016.01.002. Epub 2016 Jan 18. Review.

PMID:
26822565
2.

A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.

Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM.

J Clin Endocrinol Metab. 2016 Mar;101(3):1091-7. doi: 10.1210/jc.2015-3279. Epub 2015 Dec 16.

3.

Age of thelarche and menarche in contemporary US females: a cross-sectional analysis.

Cabrera SM, Bright GM, Frane JW, Blethen SL, Lee PA.

J Pediatr Endocrinol Metab. 2014 Jan;27(1-2):47-51. doi: 10.1515/jpem-2013-0286.

4.

A long-acting human growth hormone with delayed clearance (VRS-317): results of a double-blind, placebo-controlled, single ascending dose study in growth hormone-deficient adults.

Yuen KC, Conway GS, Popovic V, Merriam GR, Bailey T, Hamrahian AH, Biller BM, Kipnes M, Moore JA, Humphriss E, Bright GM, Cleland JL.

J Clin Endocrinol Metab. 2013 Jun;98(6):2595-603. doi: 10.1210/jc.2013-1437. Epub 2013 Apr 12.

5.

A method to determine the likelihood of transition to puberty in a heterogeneous prepubertal age group.

Frane J, Bright GM, Lee PA.

J Pediatr Endocrinol Metab. 2012;25(9-10):843-6. doi: 10.1515/jpem-2012-0116.

PMID:
23426809
6.

Recombinant insulin-like growth factor (IGF)-I treatment in short children with low IGF-I levels: first-year results from a randomized clinical trial.

Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM; MS301 Study Group.

J Clin Endocrinol Metab. 2010 Feb;95(2):611-9. doi: 10.1210/jc.2009-0570. Epub 2009 Oct 30.

PMID:
19880790
7.

Recombinant human insulin-like growth factor-1 treatment: ready for primetime.

Bright GM, Mendoza JR, Rosenfeld RG.

Endocrinol Metab Clin North Am. 2009 Sep;38(3):625-38. doi: 10.1016/j.ecl.2009.06.003. Review.

PMID:
19717008
8.

[Insulin growth factor-I-based dosing of growth hormone therapy in children: a randomized, controlled study].

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard A, Rosenfeld RG.

Probl Endokrinol (Mosk). 2009 Apr 15;55(2):27-34. doi: 10.14341/probl200955227-34. Russian.

PMID:
31569898
10.

Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.

Cohen P, Rogol AD, Howard CP, Bright GM, Kappelgaard AM, Rosenfeld RG; American Norditropin Study Group.

J Clin Endocrinol Metab. 2007 Jul;92(7):2480-6. Epub 2007 Mar 13.

PMID:
17356043
11.

Effects of dose and gender on the growth and growth factor response to GH in GH-deficient children: implications for efficacy and safety.

Cohen P, Bright GM, Rogol AD, Kappelgaard AM, Rosenfeld RG; American Norditropin Clinical Trials Group.

J Clin Endocrinol Metab. 2002 Jan;87(1):90-8.

PMID:
11788629
13.

Appraisal of growth hormone (GH) secretion: evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input.

Bright GM, Veldhuis JD, Iranmanesh A, Baumann G, Maheshwari H, Lima J.

J Clin Endocrinol Metab. 1999 Sep;84(9):3301-8.

PMID:
10487702
14.

Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.

Prakash C, Cui D, Baxter JG, Bright GM, Miceli J, Wilner K.

Drug Metab Dispos. 1998 May;26(5):448-56.

PMID:
9571226
15.
16.

Corticosteroid-binding globulin modulates cortisol concentration responses to a given production rate.

Bright GM, Darmaun D.

J Clin Endocrinol Metab. 1995 Mar;80(3):764-9.

PMID:
7883828
17.

Gas chromatographic-mass spectrometric method for measuring stable isotope enrichments of underivatized cortisol from small plasma volumes.

Bright GM, Parsons WR, Darmaun D, Rodrigues A, Haymond MW.

J Chromatogr. 1993 Nov 17;621(1):1-6.

PMID:
8308078
18.
19.
20.
21.

Variability in islet cell antibody determination: a quantitative assessment.

Bright GM, Rust PF.

Autoimmunity. 1989;3(4):281-7.

PMID:
2491633
22.

Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-AZA-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides.

Bright GM, Nagel AA, Bordner J, Desai KA, Dibrino JN, Nowakowska J, Vincent L, Watrous RM, Sciavolino FC, English AR, et al.

J Antibiot (Tokyo). 1988 Aug;41(8):1029-47.

23.

Quantitative assay for human cytoplasmic islet cell antibodies.

Bright GM.

Diabetes. 1987 Oct;36(10):1183-6.

PMID:
3308587
24.

Serositis with autoimmune endocrinopathy: clinical and immunogenetic features.

Tucker WS Jr, Niblack GD, McLean RH, Alspaugh MA, Wyatt RJ, Jordan SC, Bright GM, Pincus T.

Medicine (Baltimore). 1987 Mar;66(2):138-47.

PMID:
3493414
25.

Ambulatory management of adolescent alcohol and drug abuse.

Bright GM, Hawley DL, Siegel PP.

Semin Adolesc Med. 1985 Dec;1(4):279-92.

PMID:
3843491
26.

Bone disease in biliary atresia: a not uncommon complication.

Griffin JB, Smith CD, Bright GM.

Curr Surg. 1985 Nov-Dec;42(6):475-7. No abstract available.

PMID:
4075835
27.
28.

Autoimmunity in congenital rubella syndrome.

Clarke WL, Shaver KA, Bright GM, Rogol AD, Nance WE.

J Pediatr. 1984 Mar;104(3):370-3.

PMID:
6368774
29.

Synthesis and biological activities of 4"-deoxy-4"-sulfonamido-oleandomycin derivatives.

Bright GM, English AR, Nagel AA, Retsema JA, Sciavolino FC.

Antimicrob Agents Chemother. 1984 Jan;25(1):113-7.

30.

Naloxone attenuates recovery from insulin-induced hypoglycemia in normal man.

Bright GM, Kaiser DL, Rogol AD, Clarke WL.

J Clin Endocrinol Metab. 1983 Jul;57(1):213-6.

PMID:
6343416
31.
32.
33.

Organ-specific autoantibodies in children with common endocrine diseases.

Bright GM, Blizzard RM, Kaiser DL, Clarke WL.

J Pediatr. 1982 Jan;100(1):8-14.

PMID:
7035635
34.

Failure of cortisol blockade to inhibit early morning increases in basal insulin requirements in fasting insulin-dependent diabetics.

Bright GM, Melton TW, Rogol AD, Clarke WL.

Diabetes. 1980 Aug;29(8):662-4. No abstract available.

PMID:
7002678
35.

The rehabilitation of adolescent drug abusers: a comprehensive approach.

Bright GM.

Va Med Mon (1918). 1976 Jan;103(1):35-9. No abstract available.

PMID:
1244709
36.

The adolescent in today's society.

Bright GM.

Va Med Mon (1918). 1970 Feb;97(2):68-71. No abstract available.

PMID:
5528088

Supplemental Content

Loading ...
Support Center